Si9.0

Soy Isoflavones

Soy Isoflavones

Plant compounds with weak estrogenic effects that support menopausal symptoms, bone health, and cardiovascular function.

longevityphytoestrogenmenopausebone healthcardiovascular
Last reviewed: January 1, 2025
9.0/10
40+ studies
Evidence
moderate
Safety
40-80mg isoflavones daily
Dose
8-24 weeks
Time to Effect
Standardized soy isoflavone extract
Best Form

Soy Isoflavones are a class of phytoestrogens found in soybeans, including genistein, daidzein, and glycitein. These compounds bind to estrogen receptors with weak activity, potentially providing benefits without the risks of hormone therapy. Extensive research supports their use for hot flashes, bone health maintenance, and cardiovascular support. They're one of the most well-studied phytoestrogen supplements.

Mechanisms of Action

🔑
Estrogen Receptor Binding

Weak binding to estrogen receptors, especially ER-beta

🛡️
Antioxidant Activity

Scavenges free radicals and reduces oxidation

🦴
Bone Metabolism Support

Helps maintain bone formation over resorption

Recommended Dose

40-80mg isoflavones daily

25mg100mg

Loading: Not required; consistent daily dosing recommended

Optimal Timing

  • Divided doses with meals
  • Consistent daily timing

Take with food

Best Form

Standardized soy isoflavone extract

Alternatives: Soy protein isolate with isoflavones, Genistein-rich extracts

Look for products standardized to total isoflavone content. Some extracts focus on genistein specifically.

Duration

Minimum: 8 weeks

Optimal: 24 weeks

Cycling: Not required

Note: Absorption may vary between individuals. Equol producers (those who convert daidzein to equol) may see greater benefits.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🌡️
Reduced Hot Flashes

Fewer and less intense hot flashes

4-12 weeks
70% of users notice thispositive
🦴
Bone Density Support

Slowed bone loss, especially in spine

6-12 months
60% of users notice thispositive
❤️
Improved Cholesterol

Modest reduction in LDL cholesterol

8-12 weeks
55% of users notice thispositive
😣
GI Symptoms

May cause bloating or digestive discomfort

Initial use
15% of users notice thistrade-off
ModerateMax safe dose: 100mg/day commonly used in studies
🟢
Pregnant/nursing

Consult healthcare provider; dietary soy is generally safe

🟡
Breast cancer survivors

Discuss with oncologist; research is mixed

Who Should NOT Take This

  • Hormone-sensitive cancers (consult physician)
  • History of estrogen receptor-positive breast cancer
  • Soy allergy
  • Breast Cancer History - use with caution

Drug Interactions

Tamoxifenmajor

May interfere with anti-estrogen therapy

Thyroid medicationsmild

May affect thyroid hormone absorption; separate doses

Hormone replacement therapymild

Additive estrogenic effects

anastrozolemajor

Possible reduced effectiveness in breast cancer treatment

Possible Side Effects

GI discomfortuncommon

Tip: Take with food; start with lower dose

Bloatinguncommon

Tip: Reduce dose; may resolve with time

Warnings

  • Consult physician if history of hormone-sensitive conditions
  • Separate from thyroid medication by 4 hours

Top studies from 40+ peer-reviewed papers

meta-analysisn=5313
DOI

Akhlaghi M et al. • Critical reviews in food science and nutrition (2020)

“Soy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.”
Key Findings:
  • Soy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.
  • They increase BMD in normal weight subjects and diminish bone resorption in overweight/obese individuals.
  • Although bone resorption may be decelerated over short-term isoflavone consumption, periods longer than a year are probably needed to affect BMD.
  • Isoflavones also appear benefits on bone in any dose or subjects' ethnicity.
meta-analysisn=3285
DOI

Viscardi G et al. • Advances in nutrition (Bethesda, Md.) (2025)

“All rights reserved.”
Key Findings:
  • Addressing public health concerns may promote soy foods as high-quality plant protein sources with low environmental impact and cost, particularly benefiting postmenopausal women and aligning with sustainable dietary patterns and guidelines.
  • This study was registered in PROSPERO as CRD42023439239.Copyright © 2024 The Author(s).
  • Published by Elsevier Inc.
  • All rights reserved.
meta-analysisn=533
DOI

Luan H et al. • PeerJ (2025)

“More trials should be conducted in the future to validate our findings.©2025 Luan et al.”
Key Findings:
  • In October 2024, we screened 2,099 articles, of which 12 were eligible for meta-analysis, and found that soy isoflavones were effective for treating menopausal symptoms (seven studies, 533 participants, Hedges' g = -0.25, 95% CI [-0.42 to -0.08], p = 0.00).
  • However, our results should be interpreted with caution owing to the small sample size.
  • More trials should be conducted in the future to validate our findings.©2025 Luan et al.
meta-analysisn=5501
DOI

Zhao G et al. • Reproductive biology and endocrinology : RB&E (2025)

“Chromium, inositol, and Omega-3 were found to be beneficial for improving lipid profile.”
Key Findings:
  • Inositol significantly decreased total cholesterol and triglyceride levels, while curcumin was most effective in improving low-density and high-density lipoprotein cholesterol levels.
  • Chromium, inositol, and Omega-3 were found to be beneficial for improving lipid profile.
  • For improving obesity, sex hormone levels, inflammatory factors and oxidative stress indicators of PCOS patients, carnitine, chromium, and soy isoflavones are effective options, respectively.
  • These findings confirm that nutritional supplements can effectively alleviate PCOS symptoms, potentially providing valuable guidance for the clinical selection of appropriate nutritional interventions.
meta-analysisn=1443
DOI

Liang H et al. • Renal failure (2025)

“Through rigorous experimental validation, our study demonstrates AS's significant clinical efficacy in managing DN.”
Key Findings:
  • Meanwhile, when the treatment duration exceeds 12 weeks, AS demonstrated a significant reduction in fasting blood glucose levels, indicating a time-dependent effect.
  • Through rigorous experimental validation, our study demonstrates AS's significant clinical efficacy in managing DN.
  • Specifically, AS has been shown to enhance renal function, ameliorate renal fibrosis, and positively influence iron metabolism.
  • Despite these promising outcomes, future research with a larger sample size must be conducted to further substantiate these findings.
38
Total Studies
9.4/10
Avg Quality
13-883,627
Sample Size Range
2004-2025
Research Span

Study Type Distribution

Meta-Analysis
31
Systematic Review
6
RCT
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.